Literature DB >> 16614230

Chemotherapeutic approaches for targeting cell death pathways.

M Stacey Ricci1, Wei-Xing Zong.   

Abstract

For several decades, apoptosis has taken center stage as the principal mechanism of programmed cell death in mammalian tissues. It also has been increasingly noted that conventional chemotherapeutic agents not only elicit apoptosis but other forms of nonapoptotic death such as necrosis, autophagy, mitotic catastrophe, and senescence. This review presents background on the signaling pathways involved in the different cell death outcomes. A re-examination of what we know about chemotherapy-induced death is vitally important in light of new understanding of nonapoptotic cell death signaling pathways. If we can precisely activate or inhibit molecules that mediate the diversity of cell death outcomes, perhaps we can succeed in more effective and less toxic chemotherapeutic regimens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16614230      PMCID: PMC3132471          DOI: 10.1634/theoncologist.11-4-342

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  183 in total

Review 1.  Targeting death and decoy receptors of the tumour-necrosis factor superfamily.

Authors:  Avi Ashkenazi
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

Review 2.  Autophagy in health and disease: a double-edged sword.

Authors:  Takahiro Shintani; Daniel J Klionsky
Journal:  Science       Date:  2004-11-05       Impact factor: 47.728

3.  Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes.

Authors:  Shigeomi Shimizu; Toku Kanaseki; Noboru Mizushima; Takeshi Mizuta; Satoko Arakawa-Kobayashi; Craig B Thompson; Yoshihide Tsujimoto
Journal:  Nat Cell Biol       Date:  2004-11-21       Impact factor: 28.824

Review 4.  Necrosis is an active and controlled form of programmed cell death.

Authors:  S Ya Proskuryakov; V L Gabai; A G Konoplyannikov
Journal:  Biochemistry (Mosc)       Date:  2002-04       Impact factor: 2.487

5.  A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy.

Authors:  Clemens A Schmitt; Jordan S Fridman; Meng Yang; Soyoung Lee; Eugene Baranov; Robert M Hoffman; Scott W Lowe
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

6.  An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis.

Authors:  Youngsoo Kim; Nanjoo Suh; Michael Sporn; John C Reed
Journal:  J Biol Chem       Date:  2002-04-08       Impact factor: 5.157

7.  Different telomere damage signaling pathways in human and mouse cells.

Authors:  Agata Smogorzewska; Titia de Lange
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

8.  Cellular, biochemical, and genetic analysis of mechanism of small molecule IAP inhibitors.

Authors:  Zhiliang Wang; Michael Cuddy; Temesgen Samuel; Kate Welsh; Aaron Schimmer; Farid Hanaii; Richard Houghten; Clemencia Pinilla; John C Reed
Journal:  J Biol Chem       Date:  2004-08-27       Impact factor: 5.157

Review 9.  Cytotoxic T lymphocytes: all roads lead to death.

Authors:  Michele Barry; R Chris Bleackley
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

10.  Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves Bid cleavage.

Authors:  J J Reiners; J A Caruso; P Mathieu; B Chelladurai; X-M Yin; D Kessel
Journal:  Cell Death Differ       Date:  2002-09       Impact factor: 15.828

View more
  116 in total

1.  A small molecule with anticancer and antimetastatic activities induces rapid mitochondrial-associated necrosis in breast cancer.

Authors:  Anja Bastian; Jessica E Thorpe; Bryan C Disch; Lora C Bailey-Downs; Aleem Gangjee; Ravi K V Devambatla; Jim Henthorn; Kenneth M Humphries; Shraddha S Vadvalkar; Michael A Ihnat
Journal:  J Pharmacol Exp Ther       Date:  2015-02-26       Impact factor: 4.030

2.  A novel sphingosine kinase inhibitor induces autophagy in tumor cells.

Authors:  Vladimir Beljanski; Christian Knaak; Charles D Smith
Journal:  J Pharmacol Exp Ther       Date:  2010-02-23       Impact factor: 4.030

Review 3.  p53 and regulation of bioactive sphingolipids.

Authors:  Linda A Heffernan-Stroud; Lina M Obeid
Journal:  Adv Enzyme Regul       Date:  2010-10-28

4.  Tissue classification of oncologic esophageal resectates based on hyperspectral data.

Authors:  Marianne Maktabi; Hannes Köhler; Margarita Ivanova; Boris Jansen-Winkeln; Jonathan Takoh; Stefan Niebisch; Sebastian M Rabe; Thomas Neumuth; Ines Gockel; Claire Chalopin
Journal:  Int J Comput Assist Radiol Surg       Date:  2019-06-20       Impact factor: 2.924

5.  Proliferation inhibition effect of docetaxel combined with cisplatin on osteosarcoma cells.

Authors:  Wei Jin; Lin Cai; Guangfeng Niu; Hai Tao
Journal:  Med Oncol       Date:  2009-06-02       Impact factor: 3.064

6.  A high-throughput screen identifies miRNA inhibitors regulating lung cancer cell survival and response to paclitaxel.

Authors:  Liqin Du; Robert Borkowski; Zhenze Zhao; Xiuye Ma; Xiaojie Yu; Xian-Jin Xie; Alexander Pertsemlidis
Journal:  RNA Biol       Date:  2013-09-30       Impact factor: 4.652

7.  Comparative cellular and molecular analysis of cytotoxicity and apoptosis induction by doxorubicin and Baneh in human breast cancer T47D cells.

Authors:  P Fathi Rezaei; Sh Fouladdel; Silvia Cristofanon; S M Ghaffari; G R Amin; E Azizi
Journal:  Cytotechnology       Date:  2011-08-05       Impact factor: 2.058

8.  G226, a novel epipolythiodioxopiperazine derivative, induces autophagy and caspase-dependent apoptosis in human breast cancer cells in vitro.

Authors:  Peng-xing He; Yong-sheng Che; Qiao-jun He; Yi Chen; Jian Ding
Journal:  Acta Pharmacol Sin       Date:  2014-08       Impact factor: 6.150

9.  The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells.

Authors:  Saverio Tardito; Claudio Isella; Enzo Medico; Luciano Marchiò; Elena Bevilacqua; Maria Hatzoglou; Ovidio Bussolati; Renata Franchi-Gazzola
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

Review 10.  Heterogeneity of glycolysis in cancers and therapeutic opportunities.

Authors:  Marc O Warmoes; Jason W Locasale
Journal:  Biochem Pharmacol       Date:  2014-08-02       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.